Clinical Trials Directory

Trials / Completed

CompletedNCT05077787

Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia

Tactile and Kinaesthetic Stimulation in Preterm Neonates With Hyperbilirubinaemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Asir John Samuel · Academic / Other
Sex
All
Age
24 Hours – 10 Days
Healthy volunteers
Accepted

Summary

Hyperbilirubinemia is the most common problem seen in neonates, owing to severe complications in their lifetime. The study design of the study is pretest - a posttest experimental design. Criterion-based purposive sampling will be used for recruiting the neonates. In the study neonates will be selected according to the selection criteria and will be allocated into two groups using computer-based randomization.The Intervention group - neonates will receive tactile and kinesthetic stimulation for 15 minutes for 3 consecutive days, 1 hour after feeding twice daily along with Phototherapy, Control group - Phototherapy alone will be given along with conventional NICU care. Total serum bilirubin will be assessed as outcome measures daily once. Transcutaneous bilirubin will be assessed after every intervention.

Conditions

Interventions

TypeNameDescription
OTHERMassage therapyMassage therapy includes stroking, kneading, rolling, tapping, vibration and effleurage over the face, chest ,abdomen and back. Massage therapy will be given for 5 minutes and will be repeated twice.
OTHERKinaesthetic stimulationKinaesthetic stimulation includes passive flexion and extension movements of shoulder joint, elbow joint, hip joint, knee joint and both lower limbs together. It will be given for 5 minutes in each intervention

Timeline

Start date
2022-04-01
Primary completion
2024-01-11
Completion
2024-01-11
First posted
2021-10-14
Last updated
2024-01-29

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05077787. Inclusion in this directory is not an endorsement.

Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia (NCT05077787) · Clinical Trials Directory